BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 21743489)

  • 1. NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.
    Zhang Y; Cheng Y; Ren X; Zhang L; Yap KL; Wu H; Patel R; Liu D; Qin ZH; Shih IM; Yang JM
    Oncogene; 2012 Feb; 31(8):1055-64. PubMed ID: 21743489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-let-7f-1 regulates SPARC mediated cisplatin resistance in medulloblastoma cells.
    Pannuru P; Dontula R; Khan AA; Herbert E; Ozer H; Chetty C; Lakka SS
    Cell Signal; 2014 Oct; 26(10):2193-201. PubMed ID: 25014664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.
    Nakayama K; Rahman M; Rahman MT; Nakamura K; Sato E; Katagiri H; Ishibashi T; Ishikawa M; Iida K; Razia S; Ishikawa N; Kyo S
    Oncol Lett; 2017 Jun; 13(6):4713-4719. PubMed ID: 28599472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAC1 and HMGB1 enter a partnership for manipulating autophagy.
    Zhang Y; Yang JW; Ren X; Yang JM
    Autophagy; 2011 Dec; 7(12):1557-8. PubMed ID: 22024751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
    Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
    Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. shRNA-mediated AMBRA1 knockdown reduces the cisplatin-induced autophagy and sensitizes ovarian cancer cells to cisplatin.
    Li X; Zhang L; Yu L; Wei W; Lin X; Hou X; Tian Y
    J Toxicol Sci; 2016 Feb; 41(1):45-53. PubMed ID: 26763392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
    He J; Yu JJ; Xu Q; Wang L; Zheng JZ; Liu LZ; Jiang BH
    Autophagy; 2015; 11(2):373-84. PubMed ID: 25650716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance.
    Wang L; Zhang H; Sun M; Yin Z; Qian J
    Oncol Rep; 2015 Dec; 34(6):2969-76. PubMed ID: 26397184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
    Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
    Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
    Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
    Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells.
    Bao L; Jaramillo MC; Zhang Z; Zheng Y; Yao M; Zhang DD; Yi X
    Mol Med Rep; 2015 Jan; 11(1):91-8. PubMed ID: 25322694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-29c-3p inhibits autophagy and cisplatin resistance in ovarian cancer by regulating FOXP1/ATG14 pathway.
    Hu Z; Cai M; Zhang Y; Tao L; Guo R
    Cell Cycle; 2020 Jan; 19(2):193-206. PubMed ID: 31885310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of high mobility group box-1 in chemo-sensitivity in cervical cancer].
    Zhu F; Wu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 43(1):14-21. PubMed ID: 30154286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy.
    Qiu S; Sun L; Jin Y; An Q; Weng C; Zheng J
    Oncol Rep; 2017 Jul; 38(1):309-316. PubMed ID: 28628188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1.
    Shen C; Wang W; Tao L; Liu B; Yang Z; Tao H
    Int J Mol Med; 2013 Aug; 32(2):448-56. PubMed ID: 23722646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
    Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.
    Zhang Y; Cheng Y; Ren X; Hori T; Huber-Keener KJ; Zhang L; Yap KL; Liu D; Shantz L; Qin ZH; Zhang S; Wang J; Wang HG; Shih IeM; Yang JM
    Cancer Res; 2012 Aug; 72(16):4262-75. PubMed ID: 22665267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing Livin induces apoptotic and autophagic cell death, increasing chemotherapeutic sensitivity to cisplatin of renal carcinoma cells.
    Wang Z; Liu S; Ding K; Ding S; Li C; Lu J; Gao D; Zhang T; Bi D
    Tumour Biol; 2016 Nov; 37(11):15133-15143. PubMed ID: 27677286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma.
    Pan B; Chen D; Huang J; Wang R; Feng B; Song H; Chen L
    Mol Cancer; 2014 Jul; 13():165. PubMed ID: 24996221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nac1 interacts with the POZ-domain transcription factor, Miz1.
    Stead MA; Wright SC
    Biosci Rep; 2014 Jun; 34(3):. PubMed ID: 24702277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.